Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Neural Therapeutics Inc. ( (TSE:NURL) ) has provided an announcement.
Neural Therapeutics Inc. has reported strong financial results for its portfolio company, CWE European Holdings Inc., which operates as Hanf.com, a leading hemp and CBD-based retail platform in Germany. For fiscal year 2024, Hanf.com achieved a 65% increase in revenue, reaching $7.1 million, and returned to profitability with a positive cash flow and a double-digit operating margin. The first half of 2025 continued this growth trend with a 31% increase in revenue compared to the same period in 2024. Despite a decline in gross margin due to a shift towards lower-margin wholesale channels, the company maintained positive profitability, driven by the expansion of its retail footprint and new product lines. This performance underscores CWE’s potential to become a leading CBD and wellness retail network in Europe, with Neural holding a 30.75% ownership interest.
More about Neural Therapeutics Inc.
Neural Therapeutics Inc. is an ethnobotanical drug discovery company that focuses on developing therapeutic drugs for mental health conditions, particularly those related to substance use disorders such as alcohol and opioid dependence. The company is known for its innovative approach to drug development.
Average Trading Volume: 214,594
Technical Sentiment Signal: Strong Sell
For a thorough assessment of NURL stock, go to TipRanks’ Stock Analysis page.